Peter J. Ansell, Ph.D.
|2004||University of Missouri - Columbia, Columbia, MO, United States|
Mean distance: 11375.1
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Anderson MG, Zhang Q, Rodriguez LE, et al. (2021) ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition. Bmc Cancer. 21: 681|
|Sakla MS, Shenouda NS, Ansell PJ, et al. (2007) Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells. Endocrine. 32: 69-78|
|Ansell PJ, Zhou Y, Schjeide BM, et al. (2007) Regulation of growth hormone expression by Delta-like protein 1 (Dlk1). Molecular and Cellular Endocrinology. 271: 55-63|
|Ansell PJ, Lo SC, Newton LG, et al. (2005) Repression of cancer protective genes by 17beta-estradiol: ligand-dependent interaction between human Nrf2 and estrogen receptor alpha. Molecular and Cellular Endocrinology. 243: 27-34|
|Shenouda NS, Zhou C, Browning JD, et al. (2004) Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro. Nutrition and Cancer. 49: 200-8|
|Philips BJ, Ansell PJ, Newton LG, et al. (2004) Estrogen receptor-independent catechol estrogen binding activity: protein binding studies in wild-type, Estrogen receptor-alpha KO, and aromatase KO mice tissues. Biochemistry. 43: 6698-708|
|Ansell PJ, Espinosa-Nicholas C, Curran EM, et al. (2004) In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens. Endocrinology. 145: 311-7|